BLDE

Blade Air Mobility Inc. (BLDE) | Rumor.io

Blade Air Mobility

BLDE

Attention (50-day avg)0%

Attention rank (50-day avg)#2,823

Bullish sentiment (50-day avg)100%

Price to earnings ratio-15.5

Market capitalization423.3M

Earnings per share-0.34

Dividend yield (TTM)—

Revenue (annual)248.7M

Net income (annual)-27.3M

Social

What share of all stock conversation is about BLDE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

Aug 29

Blade Air Mobility, Inc. (now Strata Critical Medical, Inc.) has completed the sale of its Passenger business to Joby for approximately $76 million.
The company has changed its ticker symbol from $BLDE to $SRTA and is focusing on its medical logistics business, with a 2024 pro forma gross profit of $33 million and G&A of $44 million.
Strata Critical Medical has appointed new co-CEOs, Melissa Tomkiel and William Heyburn, each receiving a salary of $550,000 and performance-based stock units worth an undisclosed amount.

Generated by AI

Sentiment

Of the messages about BLDE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	99.33% +3.23
Bearish	—	—	0% 0	0.67% -3.23

Bullish· Aug 5

Blade Air Mobility's medical segment is a high-margin business with 100% hospital retention and no direct reimbursement risk, contributing 84% of 2024 Segment Adjusted EBITDA and 59% of revenue.
The company has $200M in cash post-sale, providing dry powder for acquisitions or buybacks, and a partnership with Joby adds long-term cost advantages via eVTOL access, potentially slashing transport costs by 60-70%.
The stock is undervalued in terms of future cash flows, strategic positioning, and market potential, with the current price reflecting confusion and emotional selling over the Joby deal, while the earnings report shows medical revenue up 17.6% YoY.

Bearish· Aug 4

$BLDE's passenger business was unprofitable, and the company's majority of market cap is now in cash.
Selling the core business, as $BLDE has done, is not a good deal for the company's long-term prospects.
$BLDE's decision to cash out of its urban mobility business and focus on organ transportation is seen as a negative for the company's future.

Generated by AI

Topics

Of the messages about BLDE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	99.44%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	0.56%

Aug 5

Blade Air Mobility's Q2 2025 earnings report shows a 17.6% YoY increase in medical revenue, driven by new customer onboarding and ancillary services growth.
The company has reaffirmed its 2025 guidance and achieved a record Medical Segment Adj. EBITDA of $6.0mm in Q2.
Blade's remaining medical business, Strata Critical Medical, will focus on leveraging its asset-light platform to provide mission-critical logistics and medical services to hospitals and healthcare providers.

Generated by AI

Community

Of the messages about BLDE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	2.3%	51.29%
Newcomers	100%	100%	97.7%	48.71%

Regulars· Aug 4

The deal between Joby Aviation and Blade Air Mobility involves Joby acquiring Blade's passenger business for up to $125M, with the Blade brand persisting in future livery and branding.
Blade will be renaming its remaining end-to-end air and ground medical organ transport business to Strata, which will retain equity in the company and have a pro forma market cap of $306M.
Strata's new partnership with Joby will enable it to access eVTOLs once available, enhancing profitability and complementing its existing flight and ground assets, with the deal expected to be EBITDA neutral due to cost savings.

Newcomers· Aug 6

Newcomers to Blade Air Mobility, Inc. (BLDE) are focused on the stock's performance after the recent Joby deal, with some expressing skepticism about the stock's potential.
The unusual nature of the $BLDE deal, including the CEO's apparent lack of faith in the passenger EVTOL business, is a key concern for these newcomers.
BLDE shareholders are looking forward to the company's earnings and the potential impact of the Joby deal on the stock's price, with some seeking price targets and analysis.

Generated by AI

News

Joby Aviation Files Resale Prospectus for 2.4 Million Earn-Out Shares Tied to Blade Acquisition

18d agoBenzinga

Joby reports stronger quarter, shrinking net loss, generating Blade business revenue

1mo agoYahoo Finance

Air taxis: the latest on the flying electric cars bringing the Jetsons dream to life

Here’s all the news on air taxis and flying cars.

2mo agoThe Verge

Also Discussed

Investors talking about BLDE also mention

#	Name	Attention
1	Joby Aviation, Inc.JOBY	0.02%-0.01
2	Vertical Aerospace Ltd.EVTL	0%0
3	EHang Holdings Limited Sponsored ADREH	0%+0
4	Eve Holding Inc.EVEX	0%new
5	Archer Aviation Inc. Class A Common StockACHR	0.01%-0.01
6	ARK Space & Defense Innovation ETFARKX	0.01%new
7	TransMedics Group, Inc.TMDX	0%-0.01
8	MKFG - Markforged Holding Corporation	——
9	Spire Global Inc.SPIR	0%0
10	Butterfly Network, Inc.BFLY	0.01%0

Blade Air Mobility Inc.

Industrials
Airports & Air Services

Blade Air Mobility Inc. operates within the air mobility industry, offering an innovative approach to urban and regional transportation. The company's primary function is to provide fast, cost-effective, and convenient on-demand air travel through the use of helicopters, seaplanes, and soon, electric vertical take-off and landing (eVTOL) aircraft. Blade facilitates travel by connecting passengers to flights through a streamlined app, thus integrating modern digital technology into the aviation sector. This service targets urban centers, enhancing connectivity between busy city areas and surrounding regions, and alleviating conventional transportation burdens. Blade Air Mobility Inc. stands at the forefront of the evolving urban air mobility market, playing a critical role in reducing travel time and environmental impact compared to traditional ground transportation. By supporting sustainable aviation developments, it holds a significant position in the mobility sector, shaping the future of short-distance air travel.

Website

Location

31 Hudson Yards

New York, NY, 10001

United States

Social

What share of all stock conversation is about BLDE?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% 0	0% 0

Aug 29

Blade Air Mobility, Inc. (now Strata Critical Medical, Inc.) has completed the sale of its Passenger business to Joby for approximately $76 million.
The company has changed its ticker symbol from $BLDE to $SRTA and is focusing on its medical logistics business, with a 2024 pro forma gross profit of $33 million and G&A of $44 million.
Strata Critical Medical has appointed new co-CEOs, Melissa Tomkiel and William Heyburn, each receiving a salary of $550,000 and performance-based stock units worth an undisclosed amount.

Generated by AI

Sentiment

Of the messages about BLDE that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% 0	99.33% +3.23
Bearish	—	—	0% 0	0.67% -3.23

Bullish· Aug 5

Blade Air Mobility's medical segment is a high-margin business with 100% hospital retention and no direct reimbursement risk, contributing 84% of 2024 Segment Adjusted EBITDA and 59% of revenue.
The company has $200M in cash post-sale, providing dry powder for acquisitions or buybacks, and a partnership with Joby adds long-term cost advantages via eVTOL access, potentially slashing transport costs by 60-70%.
The stock is undervalued in terms of future cash flows, strategic positioning, and market potential, with the current price reflecting confusion and emotional selling over the Joby deal, while the earnings report shows medical revenue up 17.6% YoY.

Bearish· Aug 4

$BLDE's passenger business was unprofitable, and the company's majority of market cap is now in cash.
Selling the core business, as $BLDE has done, is not a good deal for the company's long-term prospects.
$BLDE's decision to cash out of its urban mobility business and focus on organ transportation is seen as a negative for the company's future.

Generated by AI

Topics

Of the messages about BLDE that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	99.44%
Analysts	—	—	0%	0%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	0.56%

Aug 5

Blade Air Mobility's Q2 2025 earnings report shows a 17.6% YoY increase in medical revenue, driven by new customer onboarding and ancillary services growth.
The company has reaffirmed its 2025 guidance and achieved a record Medical Segment Adj. EBITDA of $6.0mm in Q2.
Blade's remaining medical business, Strata Critical Medical, will focus on leveraging its asset-light platform to provide mission-critical logistics and medical services to hospitals and healthcare providers.

Generated by AI

Community

Of the messages about BLDE, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	2.3%	51.29%
Newcomers	100%	100%	97.7%	48.71%

Regulars· Aug 4

The deal between Joby Aviation and Blade Air Mobility involves Joby acquiring Blade's passenger business for up to $125M, with the Blade brand persisting in future livery and branding.
Blade will be renaming its remaining end-to-end air and ground medical organ transport business to Strata, which will retain equity in the company and have a pro forma market cap of $306M.
Strata's new partnership with Joby will enable it to access eVTOLs once available, enhancing profitability and complementing its existing flight and ground assets, with the deal expected to be EBITDA neutral due to cost savings.

Newcomers· Aug 6

Newcomers to Blade Air Mobility, Inc. (BLDE) are focused on the stock's performance after the recent Joby deal, with some expressing skepticism about the stock's potential.
The unusual nature of the $BLDE deal, including the CEO's apparent lack of faith in the passenger EVTOL business, is a key concern for these newcomers.
BLDE shareholders are looking forward to the company's earnings and the potential impact of the Joby deal on the stock's price, with some seeking price targets and analysis.

Generated by AI

Blade Air Mobility

Social

Aug 29

Bullish· Aug 5

Bearish· Aug 4

Aug 5

Regulars· Aug 4

Newcomers· Aug 6

Joby Aviation Files Resale Prospectus for 2.4 Million Earn-Out Shares Tied to Blade Acquisition

Joby reports stronger quarter, shrinking net loss, generating Blade business revenue

Air taxis: the latest on the flying electric cars bringing the Jetsons dream to life

Also Discussed

Blade Air Mobility Inc.

Company Information

Location

Joby Aviation Files Resale Prospectus for 2.4 Million Earn-Out Shares Tied to Blade Acquisition

Joby reports stronger quarter, shrinking net loss, generating Blade business revenue

Air taxis: the latest on the flying electric cars bringing the Jetsons dream to life

Also Discussed

Social

Aug 29

Bullish· Aug 5

Bearish· Aug 4

Aug 5

Regulars· Aug 4

Newcomers· Aug 6